Tandem Diabetes Care Inc (TNDM) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
the bull case· 4
3
funds on file reporting a position in TNDM
n-portas of Jun 30 '26273
managers reporting a position in thirteen f filings
13fJun 30 '26+8.78%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '2634
managers whose positions together make up four fifths of the reported value
13fJun 30 '26the bear case· 3
1.60%
of Kilroy Realty Corp's revenue is TNDM by their own filing
10-Kfrom their filing3 of 8
recent reports where the move came in under the options implied range
earnings historyimplied vs realized0.03%
of iShares Russell two thousand ETF's assets the largest fund weight on file
n-portJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 4 '26 report. Not a forecast, not advice.
Of the 6 companies Tandem Diabetes Care Inc moves with most closely, none share its SEC classification.
Measured against 499 trading days of our own closes. Co-movement, not cause.
SIC 3841, Surgical & Medical Instruments & Apparatus, from each company's own filings. Largest first.
Tandem Diabetes Care Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Surgical & Medical Instruments & Apparatus
High 17.97 at 1:00 pm ET, low 16.22 at 7:00 am ET.
tall tick = annual report · 1 on record
273 managers report a position worth $1.3B between them, and 34 of them hold 80% of it.
TNDM (Tandem Diabetes Care Inc) has 7 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.